IP Library › Assignment 033175/0676
Patent Assignment
Reel/Frame 033175/0676

Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 5
Assignor
THERAVANCE, INC.
Executed: 2014-05-31
Assignee
THERAVANCE RESPIRATORY COMPANY, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080
Covered Properties (3)
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,528,253 →
Application: 11/204,066 →
Publication: US 2006/0116398
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Application: 12/412,194 →
Publication: US 2009/0182010
Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
Application: 60/601,781 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 11, 2004
From: MAMMEN, MATHAI; MISCHKI, TREVOR
To: THERAVANCE, INC.
Reel/Frame 015372/0294 →
Assignment of Assignor's Interest Oct 31, 2005
From: MAMMEN, MATHAI; MISCHKI, TREVOR
To: THERAVANCE, INC.
Reel/Frame 016960/0489 →
Assignment of Assignor's Interest Nov 12, 2020
From: THERAVANCE RESPIRATORY COMPANY, LLC
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 054393/0695 →